Krebs Biochemicals & Industries informs about updates on open offer

Arihant Capital Markets (‘Manager to the Offer’) has submitted a Copy of Final Letter of Offer in respect of the proposed Open Offer to the shareholders of Krebs Biochemicals & Industries (‘Target Company’) under Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 [SEBI SAST Regulations] by Ipca Laboratories Limited (‘Acquirer’).

The above information is a part of company’s filings submitted to BSE.